{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T18:19:25Z","timestamp":1785867565414,"version":"3.56.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"NIDA","award":["5U01DA033336"],"award-info":[{"award-number":["5U01DA033336"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.cct.2016.05.002","type":"journal-article","created":{"date-parts":[[2016,5,10]],"date-time":"2016-05-10T13:22:23Z","timestamp":1462886543000},"page":"57-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Extended-release naltrexone opioid treatment at jail reentry (XOR)"],"prefix":"10.1016","volume":"49","clinical-trial-number":[{"clinical-trial-number":"nct01999946","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02032433","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02110264","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02334215","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Ryan D.","family":"McDonald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babak","family":"Tofighi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Laska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Goldfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanda","family":"Bonilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Flannery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadina","family":"Santana-Correa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher W.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Leibowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Rotrosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc N.","family":"Gourevitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cct.2016.05.002_bb0005","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1056\/NEJMoa1505409","article-title":"Extended-release naltrexone to prevent opioid relapse in criminal justice offenders","volume":"374","author":"Lee","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.cct.2016.05.002_bb0010","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00213-006-0509-x","article-title":"Depot naltrexone: antagonism of the reinforcing, subjective, and physiological effects of heroin","volume":"189","author":"Sullivan","year":"2015","journal-title":"Psychopharmacology"},{"issue":"9776","key":"10.1016\/j.cct.2016.05.002_bb0015","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/S0140-6736(11)60358-9","article-title":"Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial","volume":"377","author":"Krupitsky","year":"2011","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.cct.2016.05.002_bb0020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMsa064115","article-title":"Release from prison-a high risk of death for former inmates","volume":"356","author":"Binswanger","year":"2007","journal-title":"NEJM"},{"issue":"12","key":"10.1016\/j.cct.2016.05.002_bb0025","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.2105\/AJPH.2007.121855","article-title":"All-cause and cause-specific mortality among men released from state prison, 1980\u20132005","volume":"98","author":"Rosen","year":"2008","journal-title":"Am. J. Public Health"},{"issue":"6","key":"10.1016\/j.cct.2016.05.002_bb0030","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/add.12894","article-title":"Opioid treatment at release from jail using extended-release naltrexone: a pilot proof-of-concept randomized effectiveness trial","volume":"110","author":"Lee","year":"2015","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.cct.2016.05.002_bb0035","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.cct.2014.09.002","article-title":"Design and methods of a double-blind randomized placebo-controlled trial of extended-release naltrexone for HIV-infected, opioid dependent prisoners and jail detainees who are transitioning to the community","volume":"39","author":"Di Paola","year":"2014","journal-title":"Control. Clin. Trials"},{"key":"10.1016\/j.cct.2016.05.002_bb0040","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jsat.2015.07.005","article-title":"A phase 4, pilot, open-label study of VIVITROL\u00ae (extended-release naltrexone XR-NTX) for Prisoners","volume":"59","author":"Gordon","year":"2015","journal-title":"J. Subst. Abus. Treat."},{"issue":"1","key":"10.1016\/j.cct.2016.05.002_bb0045","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/1078345814557248","article-title":"A road not taken: substance abuse programming in the New York City jail system","volume":"21","author":"Selling","year":"2015","journal-title":"J. Correct. Health Care"},{"key":"10.1016\/j.cct.2016.05.002_bb0050","series-title":"Preliminary Mayor's Management Report","year":"2014"},{"issue":"1","key":"10.1016\/j.cct.2016.05.002_bb0055","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1080\/08897077.2011.620479","article-title":"Rate of community methadone treatment reporting at jail reentry following a methadone increased dose quality improvement effort","volume":"33","author":"Harris","year":"2012","journal-title":"Subst. Abus."},{"issue":"7129","key":"10.1016\/j.cct.2016.05.002_bb0060","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/bmj.316.7129.426","article-title":"Mortality from overdose among injecting drug users recently released from prison: database linkage study","volume":"316","author":"Seaman","year":"1998","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.cct.2016.05.002_bb0065","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/10550880902772423","article-title":"Preventing death among the recently incarcerated: an argument for naloxone prescription before release","volume":"28","author":"Wakeman","year":"2009","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.cct.2016.05.002_bb0070","series-title":"Epi Data Brief: Unintentional Drug Poisoning (Overdose) Deaths Involving Opioids in New York City","first-page":"2000","author":"New York City Department of Health and Mental Hygeine","year":"2014"},{"issue":"2\u20133","key":"10.1016\/j.cct.2016.05.002_bb0075","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.drugalcdep.2010.07.002","article-title":"Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey","volume":"113","author":"Nunn","year":"2011","journal-title":"Drug Alcohol Depend."},{"issue":"9991","key":"10.1016\/j.cct.2016.05.002_bb0080","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0140-6736(14)62338-2","article-title":"Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial","volume":"25;386","author":"Rich","year":"2015","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.cct.2016.05.002_bb0085","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/002204269302300106","article-title":"The effectiveness of in-jail methadone maintenance","volume":"23","author":"Magura","year":"1993","journal-title":"J. Drug Issues"},{"key":"10.1016\/j.cct.2016.05.002_bb0090","unstructured":"Liebowitz, N., Director of Mental Health Services, Correctional Medical Associates, personal communication, 12\/1\/2015."},{"issue":"3","key":"10.1016\/j.cct.2016.05.002_bb0095","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/02791072.2010.10400696","article-title":"Heroin-dependent inmates' experiences with buprenorphine or methadone maintenance","volume":"42","author":"Awgu","year":"2010","journal-title":"J. Psychoactive Drugs"},{"issue":"2","key":"10.1016\/j.cct.2016.05.002_bb0100","article-title":"Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder","volume":"10","author":"Fox","year":"2015","journal-title":"Addict. Sci. Clin. Pract."},{"issue":"2","key":"10.1016\/j.cct.2016.05.002_bb0105","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s001270050026","article-title":"The psychometric properties of the composite international diagnostic interview","volume":"33","author":"Andrews","year":"1998","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"10.1016\/j.cct.2016.05.002_bb0110","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2015"},{"key":"10.1016\/j.cct.2016.05.002_bb0115","series-title":"Implementation of an Electronic Health Record System in the New York City Jail System, 2012. Issue Paper","author":"Stazesky","year":"2015"},{"issue":"5","key":"10.1016\/j.cct.2016.05.002_bb0120","doi-asserted-by":"crossref","first-page":"704","DOI":"10.15288\/jsad.2010.71.704","article-title":"Neurocognitive indicators predict results of an informed-consent quiz among substance-dependent treatment seekers entering a randomized clinical trial","volume":"71","author":"Kiluk","year":"2010","journal-title":"J. Stud. Alcohol Drugs"},{"issue":"2","key":"10.1016\/j.cct.2016.05.002_bb0125","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap) - a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J. Biomed. Inform."},{"issue":"1","key":"10.1016\/j.cct.2016.05.002_bb0130","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jsat.2010.03.005","article-title":"Extended-release naltrexone for treatment of alcohol dependence in primary care","volume":"39","author":"Lee","year":"2010","journal-title":"J. Subst. Abus. Treat."},{"key":"10.1016\/j.cct.2016.05.002_bb0135","series-title":"Alcohol Timeline Followback Users' Manual","author":"Sobell","year":"1995"},{"issue":"2\u20133","key":"10.1016\/j.cct.2016.05.002_bb0140","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.drugalcdep.2006.09.002","article-title":"Initial evidence for the reliability and validity of a \"Lite\" version of the addiction severity index","volume":"87","author":"Cacciola","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.cct.2016.05.002_bb0145","first-page":"68(2)","article-title":"Measuring economic outcomes of alcohol treatment using the economic form 90","author":"Bray","year":"2015","journal-title":"J. Stud. Alcohol Drug"},{"key":"10.1016\/j.cct.2016.05.002_bb0150","series-title":"Assessment of Substance Abuse: HIV Risk Assessment Battery (RAB)","author":"Metzger","year":"2001"},{"key":"10.1016\/j.cct.2016.05.002_bb0155","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1017\/S0033291798006667","article-title":"Development of the World Health Organization WHOQOL-BREF quality of life assessment","volume":"28","author":"The WHOQOL Group","year":"1998","journal-title":"Psychol. Med."},{"key":"10.1016\/j.cct.2016.05.002_bb0160","series-title":"Outcomes Assessment in clinical practice","first-page":"120","article-title":"Client satisfaction questionnaire-8 and service satisfaction scale-30","year":"1996"},{"issue":"2","key":"10.1016\/j.cct.2016.05.002_bb0165","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1001\/jama.2008.976","article-title":"Treating drug abuse in the criminal justice system: improving public health and safety","volume":"301","author":"Chandler","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.cct.2016.05.002_bb0170","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMp1402780","article-title":"Medication assisted therapies \u2013 tackling the opioid overdose epidemic","volume":"370","author":"Volkow","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cct.2016.05.002_bb0175","series-title":"Jail Inmates at Midyear 2014","author":"Minton","year":"2015"},{"key":"10.1016\/j.cct.2016.05.002_bb0180","series-title":"Prisoners in 2014","author":"Carson","year":"2015"},{"key":"10.1016\/j.cct.2016.05.002_bb0185","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.drugalcdep.2016.01.013","article-title":"Receipt of pharmacotherapy for opioid use disorder by justice-involved U.S. Veterans Health Administration patients","volume":"160","author":"Finlay","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.cct.2016.05.002_bb0190","series-title":"Jailed Heroin Addicts in Maryland can Get Treatment under New Program. The Washington Post","author":"Hicks","year":"2015"},{"key":"10.1016\/j.cct.2016.05.002_bb0195","series-title":"Breaking Good: Vivitrol, a New Drug Given as a Monthly Shot, is Helping Addicts Stay Clean. The Washington Post","author":"Tabachnick","year":"2015"},{"issue":"2","key":"10.1016\/j.cct.2016.05.002_bb0200","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1001\/archpsyc.63.2.210","article-title":"Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial","volume":"63","author":"Comer","year":"2006","journal-title":"Arch. Gen. Psychiatry"}],"updated-by":[{"DOI":"10.1016\/j.cct.2016.09.009","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000}}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714416300593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714416300593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T08:44:35Z","timestamp":1761554675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714416300593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":40,"alternative-id":["S1551714416300593"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2016.05.002","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extended-release naltrexone opioid treatment at jail reentry (XOR)","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2016.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}